These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke. Lenz T; Wilson A Clin Pharmacokinet; 2003; 42(10):909-20. PubMed ID: 12885264 [TBL] [Abstract][Full Text] [Related]
5. Newer antiplatelet therapies in stroke prevention. Davis SM; Donnan GA Aust Fam Physician; 2001 Feb; 30(2):129-34. PubMed ID: 11280112 [TBL] [Abstract][Full Text] [Related]
6. Update on clinical trials of antiplatelet therapy for cerebrovascular diseases. Bhatt DL; Kapadia SR; Yadav JS; Topol EJ Cerebrovasc Dis; 2000; 10 Suppl 5():34-40. PubMed ID: 11096181 [TBL] [Abstract][Full Text] [Related]
8. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents. Jamieson DG; Parekh A; Ezekowitz MD J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis. Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347 [TBL] [Abstract][Full Text] [Related]
10. [Old and new platelet aggregation inhibitors: which to choose for prevention of stroke?]. Devuyst G; Bogousslavsky J Rev Med Suisse Romande; 2000 Sep; 120(9):697-702. PubMed ID: 11094533 [No Abstract] [Full Text] [Related]
11. Prevention of ischaemic stroke--antiplatelets. McCabe DJ; Brown MM Br Med Bull; 2000; 56(2):510-25. PubMed ID: 11092100 [TBL] [Abstract][Full Text] [Related]
12. Aggrenox((R)) versus other pharmacotherapy in preventing recurrent stroke. Redman AR; Ryan GJ Expert Opin Pharmacother; 2004 Jan; 5(1):117-23. PubMed ID: 14680441 [TBL] [Abstract][Full Text] [Related]
13. Aggrenox: a fixed-dose combination of aspirin and dipyridamole. Lenz TL; Hilleman DE Ann Pharmacother; 2000 Nov; 34(11):1283-90. PubMed ID: 11098344 [TBL] [Abstract][Full Text] [Related]
14. [Clopidogrel in the prevention of stroke]. Nagy V; Fehér J Orv Hetil; 2004 Dec; 145(51):2563-7. PubMed ID: 15715289 [TBL] [Abstract][Full Text] [Related]
15. Antiplatelet agents for secondary prevention of ischemic stroke. Majid A; Delanty N; Kantor J Ann Pharmacother; 2001 Oct; 35(10):1241-7. PubMed ID: 11675854 [TBL] [Abstract][Full Text] [Related]
17. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice? Aw D; Sharma JC Postgrad Med J; 2012 Jan; 88(1035):34-7. PubMed ID: 22121248 [TBL] [Abstract][Full Text] [Related]
19. Aspirin should be first-line antiplatelet therapy in the secondary prevention of stroke. Warlow C Stroke; 2002 Aug; 33(8):2137-8. PubMed ID: 12154276 [No Abstract] [Full Text] [Related]
20. [Antiplatelet therapy of secondary stroke prevention after ESPS-2 and CAPRIE]. Alvarez-Sabín J; Montaner-Villalonga J Rev Neurol; 1999 Oct 16-31; 29(8):780-4. PubMed ID: 10560115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]